ADAPTeR Study: scRNA and scTCR data from TILs from two ccRCC patients treated with anti-PD1
TILs were extracted from two ccRCC patients treated with (Nivolumab) anti-PD1, one was responsive to treatment, the other non-responsive. IgG4 staining was used to separate cells into anti-PD1 bound and unbound, the samples then underwent paired scRNA and scTCR sequencing on the 10x Genomics platform.
- Type: Other
- Archiver: EGA European Genome-Phenome Archive
Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data
Determinants of anti-PD-1 response and resistance in clear cell renal cell carcinoma.
Cancer Cell 39: 2021 1497-1518.e11